National Association of Boards of Pharmacy. Catizone, MS, RPh, DPh, NABP executive director/secretary, discussed the . Neustar, a company that provides top- level domain (TLD) registry services. Read More . DEA Take- Back Day collection sites will accept unwanted medications on September 2. The theft of drugs and controlled substances by health care professionals is a serious problem that can lead to patient harm and jeopardize patient. To Controlled Substance Diversion Prevention 2.0. Road Map to Controlled Substance Diversion 2.0 . Road Map to Controlled Substance. Minnesota Department of Transportation. Resources for Controlled Substance Testing. 5 = Employee Assistance Program (EAP). Final Report: March 2012 1 Overall Purpose Controlled substance diversion by health care professionals is a serious issue that can lead to potential. Read More . In a news release, FDA explains that the.. Read More . Focusing on the immune system’s response to opioids such as morphine, researchers from the.. Read More . The PMP, known.. Minnesota News: New Prescription Monitoring Program. Controlled substance diversion by health care professionals is a serious issue that can lead to potential patient harm and/or patient safety issues. Read More . Supporters hope that such a change.. Read More . The products, X- ROCK 3 Day Pill For Men and Z- ROCK, were distributed.. Read More . The CSIP campaign will include.. Read More . With the aim of deterring abuse of the drugs, the Stop Tampering of Prescription.. Read More . The reformulated pill is more difficult to crush or dissolve, helping to prevent.. Read More . The REMS introduces.. Read More . A Department of Justice news release indicates that Torres.. Minnesota Controlled Substance Diversion Prevention Coalition 2 Coalition Structure and Workgroups The initial coalition meeting was held in June 2011. Minnesota Prescription Monitoring Program. The Minnesota Prescription Monitoring Program (PMP) is a tool to be used by prescribers and pharmacists to assist in. Read More . The agency indicates in a news release that the “action affects companies that manufacture and.. Read More . These synthetic drugs will be classified as Schedule I controlled substances in Michigan.. Read More . Drug Enforcement Administration (DEA) reports that the defendants “face 1. Read More . The 2. PSE) with.. Read More . DEA reports that Lester owned Nature and Health, a business.. Read More . PSM distributed the infographic in recognition of World Anti- Counterfeiting Day and Men's Health Week, and also.. Read More . The Legit. Script Healthcare Product Search contains data on thousands.. Read More . Attorney General Eric T. Schneiderman, Governor Andrew M. Cuomo, and New York legislators announced an.. Read More . Adderall, a drug approved to treat attention deficit hyperactivity.. Read More . If adopted as law, “patients.. Read More . Researchers used data from the 2. National Survey on Drug Use and Health (NSDUH) to determine when.. Read More . Effective April 1. Read More . HB1. 48. This bill was reintroduced from 2. The bill permits Washington State pharmacists to dispense controlled substance prescriptions written.. Read More . The meeting.. Read More . The law applies to all Schedule II CS and.. Read More . The proposed rule was published in the March 1, 2. Federal Register and extends the final order that.. Read More . This task force was established in response to Resolution 1. Control and Accountability of Prescription Medications, which was approved by the NABP membership at the.. Read More . The Bureau of Narcotics and Dangerous Drugs (BNDD) is now issuing controlled substance registrations to advanced practice registered nurses (APRNs) and physician assistants (mid- level practitioners). As of December 1, 2. Read More . The legislation builds on.. Read More . Regulators have renewed focus on the reverse distribution process in the context of a national prescription drug abuse epidemic, which creates a market for diverted drugs, and national concerns for the safety.. Read More . These products pose a threat to.. Read More . First, DEA.. Read More . According to a Department of Justice press release, the government had evidence to prove that.. Read More . Volkman faces at least 2. At the conclusion of a.. Read More . After revisions, including the removal of a provision that would have repealed the state’s prescription drug monitoring program law.. Read More . The researchers did not.. Read More . The regulations will allow for six alternative treatment centers that will both dispense.. Read More . Such a change would allow for medical uses.. Read More . The Iowa Board’s February.. Read More . The law amends the Controlled Substances Act to give the Attorney General authority to promulgate regulations to allow patients to deliver unused.. Read More . The statement, published October 6, 2. Read More . This act.. Read More . Specifically, four unidentified individuals have obtained oxycodone using fraudulent prescriptions at a number of pharmacies in Iowa. Similar cases.. Read More . The new law requires that marijuana be removed from a.. Read More . DEA recognizes that there may be confusion regarding.. Read More . There was much confusion recently.. Read More . DEA Special Agent in Charge, John J.. Read More . To date.. Read More . The hearing will take place May 4, 2. Read More . The Alabama Board of Medical Examiners is in the process.. Read More . Board staff occasionally are asked about the legitimacy of prescriptions for controlled substances written by a clinical pharmacist practitioner (CPP). There are typically two questions asked: 1. After considering evidence and.. Read More . A large number of bills related to the profession of pharmacy or to pharmaceutical manufacturers were introduced this past session. Descriptions of some of the provisions that were enacted into.. Read More . The Minnesota Legislature passed a law in 2. Board of Pharmacy to establish a controlled substances prescription electronic reporting system for all Schedule II and III controlled substance.. Read More . Computer- generated prescriptions that are either printed or faxed must be signed by the practitioner. If the printed and signed prescription is to be given to the patient to.. Read More . There is no easy way to determine.. Read More . As previously reported, in June 2. Drug Enforcement Administration (DEA) proposed a rule that would permit electronic prescribing for all schedules of controlled substances. The public comment period.. Read More . The biennial inventory may be taken on any date that is.. Read More . 1. 05- 2- 0. Title: Over- prescribing and Excessive Use of Controlled Substances and Other Prescription Medications Action: Passed Whereas, state boards of pharmacy are aware that prescription medications, including controlled substances, are being over- prescribed and used excessively, contributing to access and.. Read More . Pharmacists in the state are aware that the General Assembly enacted a Controlled Substance Reporting System in 2. Read More . What are the prescription transmission rules for legend drugs in general? Refer to Idaho Statute 5. The options are summarized as follows: Original practitioner- signed prescription Fax of original.. Read More . BZP is the common name for the synthetic drug Nbenzylpiperazine, a stimulant that is approximately 1. Read More . The pharmacist- in- charge can register with the program online and receive a.. Read More . Prescriptions must be written with the date of issue, may not exceed 9. Read More . There were also several bills that did not.. Read More ? DEA has a terrific Web site: www. The site contains lists of controlled substances by schedule, order.. Read More . The inventory was previously.. Read More . The Board frequently receives questions from pharmacists concerning the legal validity of controlled substance prescriptions that have been electronically “signed.” Such prescriptions may have the electronically captured signature of the.. Read More . For the betterment of the practice of pharmacy and ultimately for the benefit of the patient, the Nevada State Board of Pharmacy has been quite active on the regulatory.. Read More . E- mailed Schedule III to V controlled prescriptions must contain a manual signature to be valid at this time. If they are.. Read More . The comment period for these rules ended on September 2. Read More . Fraudulent prescriptions for controlled dangerous substances continue to present a significant problem to dispensing pharmacists. A Web page entitled “A Pharmacist’s Guide to Prescription Fraud,” published by the Drug.. Read More . As noted in this issue’s Disciplinary Actions, the Board recently disciplined five pharmacists and one pharmacy for involvement with Internet Web sites that offered to arrange for the sale of.. Read More . The scenario is as follows: A patient tenders a Schedule II prescription within the 1. Read More . Authorized Sales By Pharmacists) In the last three years the Board of Pharmacy has received numerous comments and complaints about the rule that required prescriptions for.. Read More . A written prescription for a controlled substance.. Read More . Filling Controlled Substance Prescription and Positive Identification: Persons receiving controlled substances shall be positively identified by the staff at the pharmacy at the time any controlled substance is.. Read More . Several laws were passed this year that will have an impact on the practice of pharmacy. Most of the pharmacy provisions in Chapter 3. Session Law were drafted.. Read More . A recent question to the Board office asked whether an “office use” prescription is valid. Medications prescribed must be dispensed to a patient. When medication is.. Read More . DEA has issued a final rule entitled “Issuance of Multiple Prescriptions for Schedule II Controlled Substances,” effective December 1. Practitioners may now provide a patient with multiple prescriptions for.. Read More . The frequently asked questions section of the Board’s Web site provides guidance on changes that may be made to a prescription for a Schedule II controlled substance after consultation.. Read More . Board staff often gets a call from either a patient or a pharmacist asking if it is OK for a pharmacist to fill multiple refills for the same prescription.. Read More . Recent communications to dispensers of controlled substances in Kentucky have highlighted the.. Read More . E- prescribed controlled.. Read More . The Drug Enforcement Administration (DEA) published in the Federal Register on November 1. Issuance of Multiple Prescriptions for Schedule II Controlled Substances.” The rule.. Read More . Drug Enforcement Administration adopted the following rule change effective December 1. The issuance of multiple prescriptions as described in this rule change is permissible under Minnesota law. Board staff is frequently asked whether and under what circumstances a transfer of prescription drugs to another pharmacy could trigger wholesaler obligations. Dan Ragan – the drug administrator for.. Minnesota Statutes. The schedules consist of the substances listed in this section by whatever official name, common or usual name, chemical name, or trade name designated. Schedule I.(a) Schedule I consists of the substances listed in this subdivision.(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following substances, including their analogs, isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of the analogs, isomers, esters, ethers, and salts is possible: (1) acetylmethadol; (2) allylprodine; (3) alphacetylmethadol (except levo- alphacetylmethadol, also known as levomethadyl acetate); (4) alphameprodine; (5) alphamethadol; (6) alpha- methylfentanyl benzethidine; (7) betacetylmethadol; (8) betameprodine; (9) betamethadol; (1. PEPAP); (4. 5) phenadoxone; (4. N- (1- Phenethylpiperidin- 4- yl)- N- phenylacetamide (acetyl fentanyl).(c) Opium derivatives. Any of the following substances, their analogs, salts, isomers, and salts of isomers, unless specifically excepted or unless listed in another schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is possible: (1) acetorphine; (2) acetyldihydrocodeine; (3) benzylmorphine; (4) codeine methylbromide; (5) codeine- n- oxide; (6) cyprenorphine; (7) desomorphine; (8) dihydromorphine; (9) drotebanol; (1. Hallucinogens. Any material, compound, mixture or preparation which contains any quantity of the following substances, their analogs, salts, isomers (whether optical, positional, or geometric), and salts of isomers, unless specifically excepted or unless listed in another schedule, whenever the existence of the analogs, salts, isomers, and salts of isomers is possible: (1) methylenedioxy amphetamine; (2) methylenedioxymethamphetamine; (3) methylenedioxy- N- ethylamphetamine (MDEA); (4) n- hydroxy- methylenedioxyamphetamine; (5) 4- bromo- 2,5- dimethoxyamphetamine (DOB); (6) 2,5- dimethoxyamphetamine (2,5- DMA); (7) 4- methoxyamphetamine; (8) 5- methoxy- 3, 4- methylenedioxyamphetamine; (9) alpha- ethyltryptamine; (1. DOM); (1. 5) ibogaine; (1. LSD); (1. 7) mescaline; (1. N- ethyl- 3- piperidyl benzilate; (2. N- methyl- 3- piperidyl benzilate; (2. TPCP or TCP); (2. N- ethyl- 1- phenyl- cyclohexylamine (PCE); (2. PCPy); (2. 6) 1- . All parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of the plant, and every compound, manufacture, salts, derivative, mixture, or preparation of the plant, its seeds or extracts. The listing of peyote as a controlled substance in Schedule I does not apply to the nondrug use of peyote in bona fide religious ceremonies of the American Indian Church, and members of the American Indian Church are exempt from registration. Any person who manufactures peyote for or distributes peyote to the American Indian Church, however, is required to obtain federal registration annually and to comply with all other requirements of law.(f) Central nervous system depressants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances, their analogs, salts, isomers, and salts of isomers whenever the existence of the analogs, salts, isomers, and salts of isomers is possible: (1) mecloqualone; (2) methaqualone; (3) gamma- hydroxybutyric acid (GHB), including its esters and ethers; (4) flunitrazepam.(g) Stimulants. Unless specifically excepted or unless listed in another schedule, any material compound, mixture, or preparation which contains any quantity of the following substances, their analogs, salts, isomers, and salts of isomers whenever the existence of the analogs, salts, isomers, and salts of isomers is possible: (1) aminorex; (2) cathinone; (3) fenethylline; (4) methcathinone; (5) methylaminorex; (6) N,N- dimethylamphetamine; (7) N- benzylpiperazine (BZP); (8) methylmethcathinone (mephedrone); (9) 3,4- methylenedioxy- N- methylcathinone (methylone); (1. MDPV); (1. 2) 3- fluoro- N- methylcathinone (3- FMC); (1. MEC); (1. 4) 1- benzofuran- 6- ylpropan- 2- amine (6- APB); (1. DMMC); (1. 6) fluoroamphetamine; (1. Unless specifically excepted or unless listed in another schedule, any natural or synthetic material, compound, mixture, or preparation that contains any quantity of the following substances, their analogs, isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of the isomers, esters, ethers, or salts is possible: (1) marijuana; (2) tetrahydrocannabinols naturally contained in a plant of the genus Cannabis, synthetic equivalents of the substances contained in the cannabis plant or in the resinous extractives of the plant, or synthetic substances with similar chemical structure and pharmacological activity to those substances contained in the plant or resinous extract, including, but not limited to, 1 cis or trans tetrahydrocannabinol, 6 cis or trans tetrahydrocannabinol, and 3,4 cis or trans tetrahydrocannabinol; (3) synthetic cannabinoids, including the following substances: (i) Naphthoylindoles, which are any compounds containing a 3- (1- napthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl or 2- (4- morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Examples of naphthoylindoles include, but are not limited to: (A) 1- Pentyl- 3- (1- naphthoyl)indole (JWH- 0. AM- 6. 78); (B) 1- Butyl- 3- (1- naphthoyl)indole (JWH- 0. C) 1- Pentyl- 3- (4- methoxy- 1- naphthoyl)indole (JWH- 0. D) 1- . Examples of naphthylmethylindoles include, but are not limited to: (A) 1- Pentyl- 1. H- indol- 3- yl- (1- naphthyl)methane (JWH- 1. B) 1- Pentyl- 1. H- indol- 3- yl- (4- methyl- 1- naphthyl)methane (JWH- 1. Naphthoylpyrroles, which are any compounds containing a 3- (1- naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl or 2- (4- morpholinyl)ethyl group whether or not further substituted in the pyrrole ring to any extent, whether or not substituted in the naphthyl ring to any extent. Examples of naphthoylpyrroles include, but are not limited to, (5- (2- fluorophenyl)- 1- pentylpyrrol- 3- yl)- naphthalen- 1- ylmethanone (JWH- 3. Naphthylmethylindenes, which are any compounds containing a naphthylideneindene structure with substitution at the 3- position of the indene ring by an allkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl or 2- (4- morpholinyl)ethyl group whether or not further substituted in the indene ring to any extent, whether or not substituted in the naphthyl ring to any extent. Examples of naphthylemethylindenes include, but are not limited to, E- 1- . Examples of phenylacetylindoles include, but are not limited to: (A) 1- (2- cyclohexylethyl)- 3- (2- methoxyphenylacetyl)indole (RCS- 8); (B) 1- pentyl- 3- (2- methoxyphenylacetyl)indole (JWH- 2. C) 1- pentyl- 3- (2- methylphenylacetyl)indole (JWH- 2. D) 1- pentyl- 3- (2- chlorophenylacetyl)indole (JWH- 2. Cyclohexylphenols, which are compounds containing a 2- (3- hydroxycyclohexyl)phenol structure with substitution at the 5- position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1- (N- methyl- 2- piperidinyl)methyl or 2- (4- morpholinyl)ethyl group whether or not substituted in the cyclohexyl ring to any extent. Examples of cyclohexylphenols include, but are not limited to: (A) 5- (1,1- dimethylheptyl)- 2- . Examples of benzoylindoles include, but are not limited to: (A) 1- Pentyl- 3- (4- methoxybenzoyl)indole (RCS- 4); (B) 1- (5- fluoropentyl)- 3- (2- iodobenzoyl)indole (AM- 6. C) (4- methoxyphenyl- .
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
January 2017
Categories |